Getinge reported a strong top line and profitability in Q3, driven by capital goods in the acute care therapies segment. Order book growth, however, was disappointing, indicating a weak Q4. The quarter also saw multiple one-offs hurting the bottom line. Organic top-line guidance was maintained at 2%-4%, which looks conservative. The company also announced the sale of the mesh business, which is embroiled in litigation, forcing SEK1.8bn of provisioning.
30 Oct 2018
Key takeaways – APAC, capital goods, one-offs and weak order book
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Key takeaways – APAC, capital goods, one-offs and weak order book
Getinge AB Class B (GTN:FRA) | 0 0 0.9% | Mkt Cap: 25,911m
- Published:
30 Oct 2018 -
Author:
Kamla Singh -
Pages:
4
Getinge reported a strong top line and profitability in Q3, driven by capital goods in the acute care therapies segment. Order book growth, however, was disappointing, indicating a weak Q4. The quarter also saw multiple one-offs hurting the bottom line. Organic top-line guidance was maintained at 2%-4%, which looks conservative. The company also announced the sale of the mesh business, which is embroiled in litigation, forcing SEK1.8bn of provisioning.